Comparative Effectiveness Research of Disease-Modifying Therapies for the Management of Multiple Sclerosis: Analysis of a Large Health Insurance Claims Database.

Neurol Ther · 2017 · PMC5447557 · PMID 28211024

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

A further study using a network meta-analysis approach reported that all three oral DMTs and GA significantly reduced the risk of experiencing at least one relapse over 1 year compared with placebo ( P < 0.05); however, the risk reduction achieved with the different IFNβ therapies did not reach statistical significance [ 14 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.